GlassScriptPhysician profile
Amy Eileen Moenning
NPI 1174203939
$2,766.72
in general payments reported to CMS, 2019-2025
33 companies · $1,046 in 2025
The $1,046 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $615 · 2024: $1,105 · 2025: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,766.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $315.83 | 2023-2025 | Ingrezza, Ongentys |
| Alkermes, INC. | $307.69 | 2023-2025 | Aristada, Lybalvi |
| Astrazeneca Pharmaceuticals LP | $272.91 | 2023-2025 | Breztri, Farxiga |
| Otsuka America Pharmaceutical, INC. | $226.01 | 2024-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Phathom Pharmaceuticals, INC. | $215.50 | 2024-2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $169.73 | 2023-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Ardelyx, INC. | $163.36 | 2023-2024 | Ibsrela |
| Abbvie INC. | $143.39 | 2023-2025 | |
| Aimmune Therapeutics, INC. | $106.22 | 2024-2025 | Zenpep |
| Astellas Pharma US INC | $87.32 | 2023-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.95 | 2023-2025 | Xifaxan |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $73.02 | 2025 | Caplyta |
| Exact Sciences Corporation | $63.86 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $62.97 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lundbeck LLC | $59.40 | 2024-2025 | Rexulti |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $46.09 | 2023-2025 | Immunocap |
| Organon LLC | $37.49 | 2023 | Nexplanon |
| Lilly USA, LLC | $35.58 | 2023 | Mounjaro, Trulicity |
| Novartis Pharmaceuticals Corporation | $31.55 | 2024 | |
| Janssen Pharmaceuticals, INC | $31.48 | 2023 | Xarelto |
| Amgen INC. | $29.89 | 2024 | Otezla, Repatha |
| Nestle Healthcare Nutrition INC. | $29.21 | 2023 | |
| Globus Medical, INC. | $25.30 | 2025 | Senza |
| Dexcom, INC. | $22.96 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $17.21 | 2023 | |
| Boston Scientific Corporation | $16.99 | 2025 | Watchman Flx |
| Eisai INC. | $16.00 | 2023 | |
| Indivior INC. | $14.83 | 2023 | Perseris |
| Merck Sharp & Dohme LLC | $13.92 | 2025 | Capvaxive, Enflonsia, Vaxneuvance |
| Sanofi-Aventis U.S. LLC | $13.90 | 2025 | |
| Collegium Pharmaceutical, INC. | $13.23 | 2023 | Belbuca |
| Pfizer INC. | $13.13 | 2024 | |
| Sumitomo Pharma America, INC. | $7.80 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Moenning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.